Related Experiment Video
Updated: Jul 5, 2025
Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
New N-Terminal Fatty-Acid-Modified Melittin Analogs with Potent Biological Activity
Sheng Huang1, Guoqi Su1, Shan Jiang1
1Animal Nutrition Institute, Chongqing Academy of Animal Science, Chongqing 402460, China.
Abstract:
Melittin, a natural antimicrobial peptide, has broad-spectrum antimicrobial activity. This has resulted in it gaining increasing attention as a potential antibiotic alternative; however, its practical use has been limited by its weak antimicrobial activity, high hemolytic activity, and low proteolytic stability. In this study, N-terminal fatty acid conjugation was used to develop new melittin-derived lipopeptides (MDLs) to improve the characteristics of melittin. Our results showed that compared with native melittin, the antimicrobial activity of MDLs was increased by 2 to 16 times, and the stability of these MDLs against trypsin and pepsin degradation was increased by 50 to 80%. However, the hemolytic activity of the MDLs decreased when the length of the carbon chain of fatty acids exceeded 10. Among the MDLs, the newly designed analog Mel-C8 showed optimal antimicrobial activity and protease stability. The antimicrobial mechanism studied revealed that the MDLs showed a rapid bactericidal effect by interacting with lipopolysaccharide (LPS) or lipoteichoic acid (LTA) and penetrating the bacterial cell membrane. In conclusion, we designed and synthesized a new class of MDLs with potent antimicrobial activity, high proteolytic stability, and low hemolytic activity through N-terminal fatty acid conjugation.
Insights
Researchers developed novel melittin-derived lipopeptides (MDLs) to enhance antimicrobial properties. These MDLs exhibit significantly improved antimicrobial activity and stability, offering a promising alternative to traditional antibiotics.
Area of Science:
- Biochemistry
- Peptide Chemistry
- Antimicrobial Research
Background:
- Melittin, a natural peptide, shows broad-spectrum antimicrobial potential.
- Limitations include weak activity, high hemolytic effects, and poor proteolytic stability.
- Need for improved antimicrobial agents drives research into peptide modifications.
Purpose of the Study:
- To develop novel melittin-derived lipopeptides (MDLs) via N-terminal fatty acid conjugation.
- To enhance antimicrobial activity, proteolytic stability, and reduce hemolytic activity of melittin.
- To investigate the antimicrobial mechanisms of the developed MDLs.
Main Methods:
- N-terminal fatty acid conjugation of melittin.
- Antimicrobial activity assays against various pathogens.
- Proteolytic stability tests using trypsin and pepsin.
- Hemolytic activity assays.
- Mechanism of action studies involving bacterial membrane interaction.
Main Results:
- MDLs demonstrated a 2- to 16-fold increase in antimicrobial activity compared to native melittin.
- Proteolytic stability against trypsin and pepsin improved by 50% to 80%.
- Hemolytic activity decreased with fatty acid carbon chain lengths exceeding 10; Mel-C8 showed optimal balance.
Conclusions:
- N-terminal fatty acid conjugation successfully created MDLs with enhanced antimicrobial efficacy.
- MDLs possess potent antimicrobial activity, high proteolytic stability, and reduced hemolytic activity.
- Developed MDLs represent a promising new class of antimicrobial agents with potential as antibiotic alternatives.
